NIR-II thermoelectric nanoplatform for metabolic reprogramming-enhanced cuproptosis in uterine tumors
Authors: Lu, Xiaojing; Zhang, Lin; Yi, Ru; Wang, Jing; Sheng, Yaru; Xu, Chen; Huang, Jiaying; Ding, Xiaoyi; Shen, Yecheng; Chen, Liang; Chen, Yu; Wang, Yudong
Source journal: Biomaterials (2026-11-09)
DOI: 10.1016/j.biomaterials.2026.124761
Abstract
Uterine tumors, including endometrial cancer (EC) and cervical cancer (CC), remain formidable threats to women's health. Unmet clinical needs include fertility preservation in younger patients, treatment of advanced or recurrent disease, limited options for patients unable to undergo surgery, and resistance to chemotherapy or radiotherapy. These challenges motivate the exploration of localized, minimally invasive, and potentially fertility-preserving energy-driven therapeutic strategies. However, the development of such nanotherapies remains constrained by material-level bottlenecks, particularly insufficient second near-infrared (NIR-II) energy utilization and suboptimal catalytic efficiency, which may limit their therapeutic efficacy. Herein, we report a second near-infrared (NIR-II)-responsive thermoelectric nanoplatform based on a conductive copper-hexahydroxyphenanthrene metal-organic framework (CuHPT) for uterine tumor therapy. Upon 1064 nm laser irradiation, CuHPT achieves exceptional photothermal conversion efficiency, establishing steep localized temperature gradients that activate an internal thermoelectric field via the Seebeck effect. This built-in field effectively suppresses charge carrier recombination, thereby enhancing catalytic reactive oxygen species (ROS) generation. Following cellular uptake, CuHPT releases intracellular copper ions and induces metabolic reprogramming characterized by elevated oxidative phosphorylation and mitochondrial hyper-respiration. This hyper-metabolic state hypersensitizes tumor cells to copper-induced proteotoxicity and is accompanied by cuproptosis, as evidenced by changes in the expression of cuproptosis-related proteins. Furthermore, CuHPT-mediated photothermoelectric therapy remodels the tumor immune microenvironment by promoting dendritic cell maturation and M1 macrophage polarization. Collectively, this study establishes an NIR-II-responsive nanoplatform that couples photothermoelectric energy conversion with metabolic reprogramming to enhance cuproptosis, providing a promising strategy for uterine tumor therapy.
Related topics
Related open access articles
- PROFILE OF INTERLEUKIN-1β IN CERVICAL CANCER PATIENTS ATTENDING ONCOLOGY UNIT, USMANU DANFODIYO UNIVERSITY TEACHING HOSPITAL, SOKOTO-NIGERIA.
- ENTEROPARASITES, RESPIRATORY ALLERGY AND OTHER SIGNS AND SYMPTOMS IN CHILDS AND YOUTH POPULATION OF RECÔNCAVO OF BAHIA – BRAZIL
- Proctocolitis in a child treated with oral immunotherapy for cow’s milk allergy
- Non-ionic Contrast Allergy Manifesting as Stevens Johnson Syndrome and Erythema Multiforme
- Can dietary intervention be an auxiliary therapy for Rheumatoid Arthritis?
- IMMUNE RELATED DISEASES AND THEIR RELATIONSHIP WITH THE GENETIC VARIABILITY WITHIN THE ADENOSINE DEAMINASE GENE
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.